Galaxy Medicare Ltd (GML) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Galaxy Medicare Ltd on NSE and BSE, with an AI summary of each filing.
Galaxy Medicare Limited has informed the Exchange about Investor Presentation
Investor Presentation · 24 Oct 2026, 11:23 pm
Galaxy Medicare Limited Releases Investor Presentation Outlining Financials and Growth Strategy Galaxy Medicare reported FY26 revenue of ₹400 Mn with an EBITDA margin of 10.75% and PAT of ₹34 Mn. Revenue channels were led by OEM/contract manufacturing at 47.8%, exports and trading at 24.5%, and domestic own brands at 22.5%. Core products—POP and Elastic Adhesive Bandages—accounted for 87% of FY26 revenue, operating at 106% and 91% capacity utilisation, respectively. Following its IPO filing on NSE EMERGE in FY25, the company is executing capacity expansions and backward integration to drive margin growth.
Galaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 30th September, 2026.
Others (Uncategorized) · 14 Oct 2026, 3:55 pm
Galaxy Medicare Confirms Non-Applicability of Corporate Governance Report for Q2 FY27 Galaxy Medicare Limited announced that corporate governance reporting under Regulation 27(2) of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended 30th Sep'26. Under Regulation 15(2), entities listed on SME platforms are exempt from compliance requirements outlined in Regulations 17 to 27, Regulation 46(2)(b)–(i)/(t), and Schedule V (Paras C, D, E). Consequently, being listed on the NSE SME Platform, the company is not required to submit a corporate governance report for the quarter.
Galaxy Medicare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 30 Sept 2026, 12:41 am
Galaxy Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
Annual General Meeting · 28 Sept 2026, 11:18 pm
Galaxy Medicare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Annual General Meeting · 04 Sept 2026, 11:49 pm
Galaxy Medicare Limited has informed the Exchange that Record date for the purpose of DI is 11-Sep-2026.
Others · 02 Sept 2026, 11:02 pm
Galaxy Medicare Limited has informed the Exchange regarding Re - Appointment of PBM & Associates, Chartered Accountant as Internal Auditor of the Company for the Financial Year 2026-2027 With Effect From August 31, 2026.
Change in Management · 01 Sept 2026, 12:22 am
Galaxy Medicare Board Approves AGM, Re-appoints Internal Auditor Galaxy Medicare's board, in its meeting on 31st Aug'26, approved the FY25-26 Director's and Annual reports. The 34th AGM is scheduled for 28th Sep'26. Key approvals include the re-appointment of PBM & Associates as Internal Auditor for FY26-27, effective 31st Aug'26. The board also appointed NSDL for e-voting services, M/s Saroj Ray & Associates as scrutinizer, and Budhaaditya Advisors Private Limited ('Stock Knocks') as the Investor Relations agency, indicating a focus on shareholder engagement and governance.
Galaxy Medicare Limited has informed the Exchange regarding the outcome of the Board Meeting held on August 31, 2026, wherein the Board approved the Notice of the 34th Annual General Meeting, including the date and time of the AGM, along with the Annual Report for the Financial Year 2025-26.
Outcome · 01 Sept 2026, 12:12 am
The Exchange had sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Others (Uncategorized) · 22 Jul 2026, 4:32 pm
Galaxy Medicare Clarifies XBRL Error and Provides IPO Fund Utilization Galaxy Medicare Ltd (GML) clarified two deficiencies from its 29 May'26 board meeting filing. An XBRL reporting error incorrectly stated paid-up equity capital as ₹15171983 instead of ₹1517.20 Lakhs due to a clerical mistake, which has now been rectified with no financial impact. Additionally, the company submitted its Working Capital Certificate, showing utilization of ₹51.20 Lakhs from IPO proceeds for the year ended 31 Mar'26. This is part of the ₹893.96 Lakhs allocated for working capital from the total IPO proceeds of ₹1,786.32 Lakhs.
Galaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 30th June, 2026.
Others (Uncategorized) · 20 Jul 2026, 8:06 pm
Galaxy Medicare (GML) Exempt from Corporate Governance Report for Q1 FY27 Galaxy Medicare Limited (GML) has informed the exchange on 20th Jul'26 that it is not required to submit the corporate governance report for the quarter ended 30th Jun'26. The exemption is claimed under Regulation 15(2) of SEBI (LODR) Regulations, 2015, which states that certain governance provisions are not applicable to companies with specified securities listed on an SME Exchange. GML's equity shares are listed on the NSE's SME Platform, hence the non-applicability of the disclosure requirement under Regulation 27(2).
The Exchange has sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Others (Uncategorized) · 27 Jun 2026, 6:01 pm